Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

AIM: To evaluates the effectiveness and safety of the first generation, NS3/4A protease inhibitors (PIs) in clinical practice against chronic C virus, especially in patients with advanced fibrosis. METHODS: Prospective study and non-experimental analysis of a multicentre cohort of 38 Spanish hospita...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Gastroenterol
Päätekijät: Salmerón, Javier, Vinaixa, Carmen, Berenguer, Rubén, Pascasio, Juan Manuel, Sánchez Ruano, Juan José, Serra, Miguel Ángel, Gila, Ana, Diago, Moisés, Romero-Gómez, Manuel, Navarro, José María, Testillano, Milagros, Fernández, Conrado, Espinosa, Dolores, Carmona, Isabel, Pons, José Antonio, Jorquera, Francisco, Rodriguez, Francisco Javier, Pérez, Ramón, Montero, José Luis, Granados, Rafael, Fernández, Miguel, Martín, Ana Belén, Muñoz de Rueda, Paloma, Quiles, Rosa
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Baishideng Publishing Group Inc 2015
Aiheet:
Prospective Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533049/
https://ncbi.nlm.nih.gov/pubmed/26290644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i30.9163
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia